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ABSTRACT
The Consensus Coding Sequence (CCDS) project
provides a dataset of protein-coding regions that
are identically annotated on the human and mouse
reference genome assembly in genome annotations produced independently by NCBI and the Ensembl group at EMBL-EBI. This dataset is the product of an international collaboration that includes
NCBI, Ensembl, HUGO Gene Nomenclature Committee, Mouse Genome Informatics and University
of California, Santa Cruz. Identically annotated coding regions, which are generated using an automated pipeline and pass multiple quality assurance
checks, are assigned a stable and tracked identifier (CCDS ID). Additionally, coordinated manual review by expert curators from the CCDS collaboration helps in maintaining the integrity and high
quality of the dataset. The CCDS data are available
through an interactive web page (https://www.ncbi.
nlm.nih.gov/CCDS/CcdsBrowse.cgi) and an FTP site
(ftp://ftp.ncbi.nlm.nih.gov/pub/CCDS/). In this paper,
we outline the ongoing work, growth and stability of
the CCDS dataset and provide updates on new col* To

laboration members and new features added to the
CCDS user interface. We also present expert curation scenarios, with specific examples highlighting
the importance of an accurate reference genome assembly and the crucial role played by input from the
research community.
INTRODUCTION
Accurate and comprehensive whole genome annotation of
the human and mouse reference genomes is essential to support many areas of scientific inquiry, including medical research. RefSeq (1) annotation from NCBI (National Center for Biotechnology Information) and Ensembl (2) annotation from EMBL-EBI (The European Molecular Biology Laboratory’s European Bioinformatics Institute) provided for these species are the primary reference resources
through which biological data are interpreted and reported
by the scientific community. The analytical workflows used
by these separate projects are conceptually similar in that
they both produce gene annotations based on a combination of computational pipelines and manual curation,
largely based on the interpretation of transcriptomics and
other experimental data. Ultimately, however, Ensembl and
NCBI have developed different rules and guidelines for au-
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tomated and manual annotation or curation, and this has
led to differences between the sets of genes, transcripts and
proteins currently found in these datasets. Such inconsistencies can present a challenge to the scientific community in
their efforts to interpret biological data; for example, when
a disease-associated variant is found to occur in a proteincoding transcript in one dataset, but a non-coding model in
another. Furthermore, the regular emergence of new data
types and methodologies with which to identify novel transcripts and to gain insights into their functionality mean
that these datasets have the potential to include additional
divergence with each new release.
The Consensus Coding Sequence (CCDS) collaboration
was formed in 2005 to address the issue of discrepancies
between Ensembl and NCBI genome annotations by producing a consensus dataset of protein-coding regions with
identical coding sequence (CDS) coordinates on the human
and mouse reference genomes in both annotations. Consensus protein-coding regions, identified by stable and tracked
identifiers (CCDS IDs), and related metadata, are accessible through a public search page (www.ncbi.nlm.nih.gov/
CCDS). In addition, data are available for bulk download
from an FTP site (ftp://ftp.ncbi.nlm.nih.gov/pub/CCDS/).
A detailed description of methods to access CCDS data, the
CCDS workflow, curation processes and quality assurance
(QA) tests involved in creating the dataset, were published
previously (3–5).
The core of the collaboration relies on consensus building across members, including NCBI who provide the RefSeq annotation, the Ensembl Genebuild and Ensembl HAVANA (Human and Vertebrate Analysis and Annotation)
groups at EMBL-EBI who produce the GENCODE (6)
gene set, University of California Santa Cruz (UCSC), and
the two nomenclature authorities, HUGO Gene Nomenclature Committee (HGNC) (7) and Mouse Genome Informatics (MGI) (8) who provide standardized human and
mouse gene symbols and names, respectively. To maintain
high-quality annotation, expert curators from the collaborating groups continuously review and discuss CCDS IDs
flagged for review by QA tests, collaboration members and
users. Curators also review regions where there are differences in protein annotation between the NCBI and Ensembl genome annotations, to try to reach consensus using all available data types through a voting process, which
is described in an earlier publication (4). The combination
of CDS annotation concordance across two groups with
different annotation methods and policies, and the regular review of the resource by expert curators make CCDS
data, a stable and high-confidence option for users focused
on protein-coding genes that are annotated consistently in
the two major annotation databases. Therefore, CCDS data
have been used in genome analyses, such as comparison of
whole-genome sequencing and whole-exome sequencing for
effective detection of disease-causing mutations (9), largescale evaluation of proteomics data to determine if genes
have a dominant protein isoform (10) and high-throughput
exome coverage analysis of clinically relevant cardiac genes
(11). In addition, CCDS data are used to design commercial
exome microarrays (12).
In this manuscript, we present the current status of the
CCDS collaboration, describe the updates that have been
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Figure 1. Number of CCDS IDs and genes represented in the human (A)
and mouse (B) CCDS releases. The X-axis indicates the year in which a
CCDS dataset was made public. Details about CCDS releases are available
on the CCDS Releases and Statistics web page (https://www.ncbi.nlm.nih.
gov/CCDS/CcdsBrowse.cgi?REQUEST=SHOW STATISTICS).

made to the CCDS resource since our last report, and we
highlight some of the challenges and future plans of this
ongoing and active collaboration.
GROWTH OF THE CCDS DATASET
The CCDS collaboration releases an update of the human
and mouse CCDS datasets approximately once each year,
following annotation updates of the reference genomes by
either NCBI or Ensembl, or both annotation groups. Since
the first human and mouse data releases in 2005 and 2006,
respectively, the CCDS dataset has seen a steady growth in
the number of new coding regions (CCDS IDs) as well as
the number of genes that have at least one CCDS ID in both
the human (Figure 1A) and mouse (Figure 1B) datasets.
This growth reflects increasing concordance in NCBI and
Ensembl protein-coding region annotations over the years.
The most recent CCDS releases in human (Release 20) and
mouse (Release 21) contain 32 524 and 25 757 CCDS IDs
represented by 18 892 and 20 354 genes, respectively, and
cover ∼33.2 Mb (1.03%) of the human and 33.7 Mb (1.24%)
of the mouse reference genomes. Notably, the growth in recent years is largely due to the addition of new CCDS IDs
representing alternatively spliced transcripts within existing protein-coding genes, and this trend has continued un-
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Figure 2. Fraction of all genes in a CCDS release that are represented by
at least two current CCDS IDs.
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abated up to the current human and mouse releases. This is
evident from Figure 2, which shows a growing trend in the
fraction of total genes in the CCDS dataset that are represented by at least two protein isoforms in both the mouse
and the human CCDS sets. The increase in detectable splicing variation can be attributed to the identical annotation
of alternatively spliced transcript variants resulting from the
incorporation of new data types into automated pipelines,
as well as curation workflows of the two annotation groups.
It also likely reflects an end to the locus-by-locus ‘growth
phase’ of human annotation as both annotation groups
have manually annotated most human genes in their respective annotation catalogs, and are expected to reach the same
goal in mouse annotation in the next few years. Nonetheless, the protein-coding gene count remains dynamic in
both annotation catalogs; we anticipate that both Ensembl
and NCBI will continue to add and remove protein-coding
genes in future releases.
Notably, despite a greater number of protein-coding
genes in the mouse than in the human dataset (as seen in
Figure 1), the Figure 2 graph shows lower numbers for multiple isoform representation in the mouse data. This is likely
due to the prioritization of curating the human annotation
by both annotation groups. In recent years, however, mouse
curation has received increasing focus at both Ensembl and
NCBI, and this is expected to narrow the gap in the number
of CCDS IDs between the human and mouse datasets in future CCDS releases. New human and mouse CCDS releases
are planned before the end of 2017.
The general slow-down in growth over recent releases
(Figures 1 and 2) also suggests increasing stability in the
dataset. To evaluate dataset stability, we assessed the rates
of change for CCDS IDs between releases, including additions of new CCDS IDs, updates to existing CCDS IDs (indicated by an increment in the CCDS ID version) and withdrawals of CCDS IDs. Our analyses (Figure 3) show that
larger numbers of CCDS updates and withdrawals occurred
between earlier CCDS releases than recent CCDS releases.
These results indicate that the CCDS dataset is becoming
increasingly stable, not only at the level of new additions,
but also at the level of individual CCDS ID alteration.
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Figure 3. Changes in the human (A) and mouse (B) datasets with every
new CCDS release. ‘New’ = new CCDS IDs added; ‘dropped’ = CCDS
ID present in the previous release but withdrawn in the subsequent release;
‘updated’ = CCDS IDs that have an incremented accession version compared to the previous release, indicating a sequence update in the coding
region.

CCDS DATABASE UPDATES
Collaborators
In May 2014, the official human and mouse nomenclature
groups, HGNC and MGI, respectively, replaced UCSC as
voting members of the collaboration. UCSC is no longer
an active participant in CCDS curation, although they still
provide QA input on pseudogenes, orthology and conservation during automated CCDS analysis. Representatives
from HGNC and MGI are involved in CCDS policy decisions and in review of specific annotation cases. As voting
members in the CCDS annotation review process, they provide input on all cases of conflict between NCBI and Ensembl annotations, highlight individual genes for consideration and raise policy issues for discussion. Their involvement also facilitates timely nomenclature updates prompted
by CCDS curation.
Guidelines
Coordinated curation of human and mouse coding region annotation by experts in the CCDS collaboration
is crucial for maintaining the high quality of the CCDS
dataset. As different collaborating groups may follow di-
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verse rules for curation, a common set of guidelines was
established for consistent and efficient curation within the
CCDS collaboration. These guidelines are available on the
CCDS web page (https://www.ncbi.nlm.nih.gov/projects/
CCDS/docs/CCDS curation guidelines.pdf) and are described in detail in a previous report (4). Curation guidelines need to be updated in response to discussions among
collaborators, feedback from research groups and emerging data types. Several updates to CCDS guidelines have
been made since our last publication (5) and they reflect
changes in CCDS curation policies, which are described in
previous reports (4,5). The updates include rules pertaining
to the selection of translation start codons and guidelines
for the representation of nonsense-mediated mRNA decay
(NMD), inferred exon combination and readthrough gene
representations. Section 2A, which contains guidelines for
start codon selection, was updated to add rules to allow the
use of an in-frame downstream start codon instead of the
first start codon in the open reading frame (ORF). Specific
case examples were included to illustrate scenarios and the
support needed to choose the downstream start codon.
The existence of upstream ORFs (uORFs) in proteincoding transcripts were previously considered to be evidence for the removal of the protein-coding capacity of a
transcript. In literature-led discussions within the collaboration, it was decided that uORFs are predominantly regulatory rather than deterministic, so they are no longer considered in annotating the CDS.
A new section (Section 2B) was added to the guidelines to
describe rules pertaining to CDS annotation in cases where
the location of the translation start codon suggests that the
transcript may be subject to NMD. Another section (Section 2D) was added to describe the CDS annotation for
transcripts that lack full-length support, i.e. a transcript
archived in an International Nucleotide Sequence Database
Collaboration (INSDC) (13) database and includes at least
the entire coding region. In some of these cases, a full-length
protein can be inferred from homology, orthology or publications. In other cases, the coding region is inferred when
the gene contains cassette exons that are supported individually by transcript, conservation or published data, but fulllength support is lacking. A good example of this is TTN
(CCDS59435.1) which has 363 exons.
A readthrough transcript is annotated when neighboring genes share transcripts that overlap at least one exon
per gene. Historically a ‘3-gene model’ was used where the
readthrough transcript is considered a part of a separate
gene. A CCDS was generated when there was NCBI and
Ensembl consensus annotation of a coding readthrough
transcript. In some cases, where the overlapping region included only the untranslated region (UTR) of the upstream
gene, the readthrough transcript could share the CDS (and
hence, the CCDS ID) with the downstream genes, which
caused confusion. As transcriptional data are increasing
at an exponential rate, we are finding that the existence
of readthrough transcripts is very widespread and most
readthrough transcripts are likely to be non-functional.
Hence, they will now only be considered for inclusion in the
CCDS dataset when there is strong experimental evidence
for their existence and the CDS is unique.
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User interface
A CCDS report page includes links to genome browsers in
the ‘Chromosomal Locations’ section (purple icons) that
display the genomic span of the coding sequence (‘Genome
Browser links’) or genomic span of individual coding exons (browser links in the exon table). In 2014, an additional
link (purple ‘S’ icon) was included in the last column of
the report table at the top of the CCDS report page. This
link opens an interactive combined graphical display (Figure 4) of the NCBI and Ensembl annotations associated
with the CCDS ID, using the NCBI Sequence Viewer tool.
The graphical display offers several options to customize
the browser view, including the ‘Tracks’ button, which allows a user to load additional data tracks to the default
view.
The curated SwissProt subset of the UniProtKB (14)
database provides additional data relevant to a protein, including function, protein features, subcellular location, expression and structure. To provide access to this data to
CCDS users, since January 2014, CCDS reports include
a section that displays the UniProtKB/SwissProt accession, including the specific isoform, that matches the CCDS
(example CCDS4565.1). The hyperlinked accession number in the ‘Related UniProtKB/SwissProt’ column provides
the user a direct link to the UniProtKB/SwissProt record.
These CCDS:SwissProt accession matches are also available
in the CCDS2UniProtKB.[release date/current].txt files in
the CCDS FTP site.
Review status
While the CCDS dataset results from concordant annotation in two independent annotation sets, it also reflects manual review by curators from the Ensembl and NCBI annotation groups and by curators in the CCDS collaboration.
The greatest value of manual annotation is in the insights
it can provide into the functionality of a given transcript,
i.e. our understanding of what that transcript does (for example, encodes a protein) and the ability to critically assess
the validity of all primary data. In 2017, a ‘Review Status’
section was added to the CCDS report page above the ‘Sequence IDs’ table to convey to users if a CCDS ID has been
reviewed. Table 1 summarizes the different categories of review status with a brief description of each category. The review status depends on manual review carried out at two levels. The first level of review is performed by curators in the
individual annotation groups who review genes, transcripts
and proteins as a part of their manual annotation process,
and this review is independent of the CCDS workflow. Transcripts and proteins are then flagged within each annotation
set to indicate their review status. NCBI-RefSeq accessions
are flagged as ‘validated’ or ‘reviewed’. In the Ensembl annotation set, a transcript that is manually annotated has
a VEGA (Vertebrate Genome Annotation) (15) accession
(with ‘OTT’ prefix) in addition to an Ensembl (‘ENS’ prefix) accession, which is indicated in the Transcript window
of the Ensembl genome browser. When the two annotations
are compared to generate the CCDS set, transcripts and
proteins that have gone through this level of review, and
are annotated identically in the Ensembl and NCBI sets, result in CCDS IDs with a ‘Reviewed (by RefSeq and HA-
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Figure 4. A view of the graphical display accessed from the report page of CCDS3542.1 (https://www.ncbi.nlm.nih.gov/CCDS/CcdsBrowse.cgi?
REQUEST=ALLFIELDS&DATA=CCDS3542&ORGANISM=0&BUILDS=CURRENTBUILDS) using the purple ‘S’ icon. (A) Transcripts and proteins from NCBI Annotation Release 108. (B) Transcripts and proteins from Ensembl Release 85. The green bar indicates the gene; transcripts are shown
in purple and proteins are shown in red color. Positioning the cursor over any of these objects (gene, transcript or protein) opens a tool tip which includes
additional information and links. Proteins in the NCBI annotation display that are in the CCDS set include a link to the CCDS ID in the tool tip. The gray
box to the right (indicated by vertical arrow) is the tool tip corresponding to the protein accession NP 002514.1. Differences between any two objects can
also be revealed as vertical lines (indicated by horizontal arrows) when the objects (NM 002523.2 and ENST00000265634 in the figure) are selected using
the ‘Control’ or ‘Command’ button on the keyboard.
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VANA)’ status (example CCDS83093.1). It is noteworthy
that the VEGA genome browser was retired and archived
early in 2017 but manually annotated transcripts continue
to be accessible in the Ensembl genome browser. In Ensembl
release files, manually annotated transcripts are indicated as
ensembl havana or havana.
A second level of manual review includes the review
of CCDS IDs flagged by QA tests for errors or inconsistencies. In addition, specific review cases are raised
by individual collaborators or external databases (e.g.
UniProt/SwissProt). CCDS users can also request the
review of CCDS IDs through the user contact interface (https://www.ncbi.nlm.nih.gov/CCDS/UserRequest/
UserRequest.cgi). Internally, these cases either involve
a discussion and voting process described in an earlier
report (4) or have a ‘Public Note’ on the CCDS report
page explaining an update that was made to the CCDS
record. This level of review results in the CCDS ID being designated as ‘Reviewed (by CCDS collaboration)’
(example CCDS48347.1). CCDS IDs that meet both
above-mentioned levels of review get the ‘Reviewed (by
RefSeq, HAVANA and CCDS collaboration)’ label (example CCDS16957.2). Conversely, CCDS IDs that do
not meet any of these levels of review are assigned the
‘Provisional’ review status (example CCDS45069.1).
Figure 5 shows the distribution of human and mouse
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Figure 5. Distribution of human and mouse CCDS IDs by their ‘Review
status’ in the current human (Release 20) and mouse (Release 21) CCDS
releases at the time of data freeze. Details of the review status categories
and sub-categories are provided in Table 1. Reviewed 1 = CCDS IDs reviewed ‘by RefSeq and HAVANA’, Reviewed 2 = CCDS IDs reviewed ‘by
CCDS collaboration’, Reviewed 3 = CCDS IDs reviewed ‘by RefSeq, HAVANA and CCDS collaboration’.

CCDS IDs among these review categories. Review status is
available only for the CCDS IDs of the current release. At
the time of the data freeze for the CCDS release, the current
human CCDS set (Release 20) had 30 181 (out of a 32 524
total) ‘Reviewed’ CCDS IDs, while the current mouse set
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Table 1. Description of CCDS ‘Review Status’ categories
Review status category
Provisional

Public description of category
‘this record has not been manually reviewed
by the collaboration’

Reviewed

• ‘by RefSeq and HAVANA’
• ‘by CCDS collaboration’
• ‘by RefSeq, HAVANA and CCDS
collaboration’

(Release 21) had 16 740 (out of a 25 757 total) ‘Reviewed’
CCDS IDs.

Expert curation
The CCDS collaboration continues to provide expert curation support to the human and mouse datasets. Since
our last publication, the CCDS collaboration reviewed several genes which led to improved annotation that is more
consistent with the supporting data. For example, a new
gene, ASDURF (ASNSD1 upstream reading frame) was defined based on transcript data and conservation of the 96
amino-acid protein, which was included earlier as a product of the ASNSD1 gene (Human CCDS2300.1; Mouse
CCDS14954.1, CCDS69888.1). The CCDS collaboration
reviews genes that are currently annotated as non-coding
genes, but where recent evidence indicates they may encode small proteins. For example, the human gene SMIM27
(NCBI GeneID:100129250, ENSG00000235453, formerly
TOPORS-AS1) and its mouse ortholog Smim27 (NCBI
GeneID:100504309, ENSMUSG00000028407) are now annotated as protein-coding genes, based on orthology, ribosome profiling elongation and PhyloCSF (16) data.
On several occasions, the CCDS collaboration has
worked with scientific research groups to improve annotation of genes. A notable example of the benefit of cooperative expert curation is reflected in the updated annotation
of human MIA2 and CTAGE5 and their mouse orthologs,
following a discussion of these genes by the CCDS collaboration, prompted by a review request from the UniProt
group. These genome features were annotated as independent genes by NCBI (Annotation Release 108) and Ensembl (Release 85). CCDS collaborators merged the two
genes into a single gene, MIA2, based on published data
on the human (17) and mouse (18) genes, direct consultations with the research groups and new data submitted to INSDC (KX388743.1, representing the TANGO1like transcript, TALI, which contains both MIA2-specific
and CTAGE5-specific exons). The CTAGE5 protein was retained as a splice variant of MIA2 and a new transcript variant (RefSeq transcript NM 001329214.2; Ensembl transcript ENST00000640607.1), based on TALI, was created.
Similar changes were made in the representation of the
mouse Mia2 gene as well. Following these changes, the
nomenclature groups agreed to merge their records and
retain the symbol MIA2 and Mia2, for the human and
mouse genes, respectively. Such annotation changes made
by CCDS curators are reflected in the subsequent updates
of the NCBI and Ensembl genome annotations. The CCDS
dataset reflects the change in the new CCDS build, which,
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Detailed description
The CCDS ID does not have a ‘validated’ or ‘reviewed’ RefSeq or a
VEGA accession associated with it; nor was it reviewed by the CCDS
collaboration
• The CCDS ID is associated with at least one ‘validated’ or ‘reviewed’
RefSeq AND at least one VEGA accession, which are manually reviewed
by curators at NCBI and Ensembl-HAVANA groups, respectively.
• The CCDS ID was reviewed by curators in the CCDS collaboration.
• The CCDS ID meets both ‘by RefSeq and HAVANA’ and ‘by CCDS
collaboration’ review requirements.

as mentioned earlier, is typically released after NCBI and
Ensembl produce updated versions of their gene sets.
In addition to the manual review of specific genes or
CCDS IDs, the collaboration regularly reviews targeted lists
with a common goal. For example, curators recently reviewed a list of around 250 genes that are annotated by both
Ensembl and NCBI, but have different gene biotypes (typically protein-coding versus pseudogene versus long noncoding RNA). As a result of this review, both annotation
groups agreed on consistent gene biotypes for about 70
genes. Where disagreements remain, a common factor is
the lack of sufficient transcriptomic or proteomic evidence
to confirm or confidently suggest a biotype. These cases
will be subject to iterative review as additional data become available. A second task involved the review of genes
(86 human and 130 mouse genes) that were represented in
the CCDS database, but had differing gene symbols in the
NCBI and Ensembl databases. This review led to the correction of gene symbols in both annotation sets based on
standard names provided by the respective nomenclature
authorities. Last year, the CCDS collaborators undertook
a review of human-mouse orthologs to ensure that both orthologs were represented in the CCDS dataset when supporting data were available. Such targeted curation on a
regular basis ensures the accuracy and consistency of the
CCDS dataset.
Sometimes, accurate annotation of coding regions is limited by factors that are beyond the control of annotation
pipelines and expert curators. Despite several rounds of improvement, human and mouse reference genome assembly
errors continue to pose a challenge for accurate CCDS annotations. CCDS curators continue to report genome problems to the GRC (Genome Reference Consortium) (19),
who provide curation support to improve the reference
genome assemblies of select organisms, including human
and mouse. The resolution of genome assembly errors in a
new assembly version results in the addition of new CCDS
IDs due to improved gene representations in the NCBI and
Ensembl annotations. For example, CCDS75980.1 (human
gene DGKK) was gained following consensus annotation on
the GRCh38 (20) assembly after a single nucleotide deletion which existed in the GRCh37 assembly was fixed. In
total, about 150 human CCDS IDs were gained based on
the GRCh38 assembly following the resolution of genome
assembly problems that existed in the GRCh37 assembly.
Data types used in manual curation
New, improved or more highly robust data types that support gene, transcript or protein existence continue to emerge
through biological research. Expert curators in the CCDS
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Table 2. Data types used in CCDS manual curation decisions
Data type
RNA-seq (24)
CAGE tags (25)
H3K4me3 methylation
CpG islands
Long read transcriptome data
Proteomics
Ribosome profiling
Conservation in other species
Conserved protein domains
PhyloCSF
polyA-seq (26)

Curation decisions
Determination of transcript or gene structure or extent, inferred exon combination, splice variant existence
Determination of transcription start sites, 5 UTR extension
Determination of general 5 completeness of transcripts or genes
Determination of general 5 completeness of transcripts or genes (in conjunction with other data)
Splice variants; especially useful for genes with poor INSDC transcript support
Determination of gene biotype, novel exons, novel protein termini.
Determination of translation start codons or the coding status of genes with questionable biotypes
Determination of gene biotype, annotation of proteins with little or no data about gene function, determination
of translation start codon
Determination of gene biotype, annotation of proteins with little or no data about gene function
Determination of gene biotype, annotation of uncharacterized proteins
Determination of 3 completeness

collaboration adapt to such data types and incorporate
them in curation/annotation workflows to provide accurate
coding region annotations. Table 2 lists the more recent data
types that have been adopted by CCDS curators to make
key decisions. Most of the listed data types are used in manual review and are not yet incorporated in the automated
annotation pipelines (except short-read and long-read transcriptome data). Typically, these data types are considered
for genes that lack traditional support such as mRNAs and
ESTs which are archived by INSDC databases, or they may
lack information about gene function. Hence, such genes
are reviewed on a case-by-case basis with additional support gleaned from newer data types where appropriate.
CONTRIBUTIONS FROM RESEARCH COMMUNITIES
Almost all the annotation included in the CCDS dataset is
evidence-based and is supported by experimental data, including transcript, protein and other data types (Table 2)
submitted by the research community to public databases
such as INSDC. The curation examples cited in this paper
underline the importance of sequence data submitted by research groups to public archives, as well as data published
in peer-reviewed journals, for improving gene annotation. A
small percentage of protein-coding genes remain excluded
from the CCDS dataset owing to the lack of sequence data
and lack of any information that would indicate the function of the gene. New data may lead to the consensus annotation of these genes in the NCBI and Ensembl annotation
sets, and thus, their inclusion in the CCDS dataset. Therefore, it is important that research groups submit sequence
data generated by them to public archives. Further, studies
in hitherto uncharacterized genes will serve as a crucial resource and help CCDS curators improve their annotation.
The CCDS collaboration also welcomes direct input from
the research community for the annotation of specific genes
and gene families. Such input can be communicated via the
user contact email link, as mentioned above.
FUTURE DIRECTIONS
Although dataset analyses indicate the addition of new annotation and stability in the existing consensus annotation
of protein-coding regions in the Ensembl and NCBI annotations (Figure 1), a small percentage of genes still lack consistent annotation. These may be cases where one group has
annotated a coding gene and the other has not; the latter
may have annotated a gene with a different gene type––i.e.
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non-coding or pseudogene––or may not have described any
gene at all. Such cases are naturally a top priority for review
by the CCDS curators. In particular, the interpretation of
genes predicted to encode small proteins or small open reading frames (smORFs) and non-coding RNAs pose challenges for gene annotation (21,22), and thereby pose challenges for the completion of the CCDS dataset. Interpretation of new datasets including ribosome profiling, crossspecies conservation, evolutionary conservation of synonymous codons in ORFs and mass spectrometry promises
to help resolve some of the uncertainty about these genes.
Nonetheless, gene-level biotype differences may persist between the Ensembl and NCBI annotation sets even after
some of these genes have been debated. Such cases ultimately reflect differences between the annotation guidelines
of these projects, specifically on how to judge the balance of
probability when the evidence for annotation is limited or
ambiguous.
While the CCDS project assists navigation between the
Ensembl and NCBI databases, users may be confused by
inconsistent terminology used by different annotation and
nomenclature groups to describe gene and transcript biotypes. To provide consistent terms and further enhance navigation across different genome annotation resources, all
members of the CCDS collaborative group have, or plan to,
implement Sequence Ontology (23) terms to label genome
feature biotypes.
Data pertaining to the ‘Review status’ (Figure 5) indicate
that there are still a significant number of mouse CCDS IDs
and a smaller number of human CCDS IDs that lack a ‘Reviewed’ status. It is our aim to review all provisional CCDS
IDs with a goal of eventually providing completely reviewed
human and mouse CCDS datasets.
Although the primary focus of the CCDS collaboration
is the representation of protein-coding regions, it is also a
platform for members of major bioinformatics resources
to discuss new ideas, share strategies about using emerging
data types for genome annotation and predict user needs
based on the latest research trends. For example, user interest has spurred recent discussions in topics such as reconciling the UTRs of transcripts across independent annotation sets and assigning one representative transcript per
gene. Further discussions and analyses are needed to explore providing potential deliverables based on these ideas.
The CCDS collaboration continues in its pursuit to provide
agreement in the annotation of human and mouse proteincoding genes in reference gene sets while constantly adapting to emerging data types and user needs. With the help of

D228 Nucleic Acids Research, 2018, Vol. 46, Database issue

new data in public archives and input from research groups,
we will continue working toward the long-term goal of providing consistent and stable annotation of protein-coding
genes on the human and mouse reference genome assemblies.
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